Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsu Hirakawa

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cureus|July 12, 2026
Kakkonto-Induced Pneumonitis: A Case ReportIkuko Ooka, Tetsu Hirakawa, Yoshito Temma, et al.
Modern Rheumatology Case Reports|January 30, 2023
Giant cell arteritis with myeloperoxidase anti-neutrophil cytoplasmic antibody seropositivity in a patient with systemic sclerosisYoshihiro Kitahara, Rie Nakamura, Makiko Kawai, et al.
Cancer Reports (Hoboken, N.J.)|February 2, 2023
Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancerKosuke Hamai, Shinya Miyaka, Shinpei Tada, et al.
Cancer Control : Journal of the Moffitt Cancer Center|August 9, 2024
A Retrospective Analysis of the Efficacy of Oral Dexamethasone in Combination With Docetaxel Plus Ramucirumab Therapy for Previously Treated Lung CancerKosuke Hamai, Ryo Katsura, Shinya Miyake, et al.
Internal Medicine (Tokyo, Japan)|August 16, 2023
Pseudomesotheliomatous Carcinoma of the Lung with Morphological Characteristics of Signet Ring Cell Carcinoma: An Autopsy Case ReportTetsu Hirakawa, Takuya Tanimoto, Yui Hattori, et al.
International Journal of Clinical Oncology|July 6, 2026
Correction: Clinical implications of serum total VEGF-A and VEGF-A isoforms in patients with EGFR-mutated advanced non-small cell lung cancer treated with EGFR-TKIsTetsu Hirakawa, Kakuhiro Yamaguchi, Kiyofumi Shimoji, et al.
International Journal of Clinical Oncology|June 9, 2026
Clinical implications of serum total VEGF-A and VEGF-A isoforms in patients with EGFR-mutated advanced non-small cell lung cancer treated with EGFR-TKIsTetsu Hirakawa, Kakuhiro Yamaguchi, Kiyofumi Shimoji, et al.
Internal Medicine (Tokyo, Japan)|October 1, 2025
Diffuse Pulmonary Meningotheliomatosis Presenting with the Cheerios Sign Diagnosed by a Transbronchial Lung Cryobiopsy: A Case ReportTetsu Hirakawa, Kiyofumi Shimoji, Sachiko Shioya, et al.
Cancers|February 26, 2025
Predictive Value of Circulatory Total VEGF-A and VEGF-A Isoforms for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small-Cell Lung CancerTetsu Hirakawa, Kakuhiro Yamaguchi, Kunihiko Funaishi, et al.
Anticancer Research|July 7, 2021
Systemic Inflammatory Score Predicts Response and Prognosis in Patients With Lung Cancer Treated With ImmunotherapyJunichi Zaitsu, Yoshinori Yamashita, Akira Ishikawa, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cureus|July 12, 2026
Kakkonto-Induced Pneumonitis: A Case ReportIkuko Ooka, Tetsu Hirakawa, Yoshito Temma, et al.
Modern Rheumatology Case Reports|January 30, 2023
Giant cell arteritis with myeloperoxidase anti-neutrophil cytoplasmic antibody seropositivity in a patient with systemic sclerosisYoshihiro Kitahara, Rie Nakamura, Makiko Kawai, et al.
Cancer Reports (Hoboken, N.J.)|February 2, 2023
Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancerKosuke Hamai, Shinya Miyaka, Shinpei Tada, et al.
Cancer Control : Journal of the Moffitt Cancer Center|August 9, 2024
A Retrospective Analysis of the Efficacy of Oral Dexamethasone in Combination With Docetaxel Plus Ramucirumab Therapy for Previously Treated Lung CancerKosuke Hamai, Ryo Katsura, Shinya Miyake, et al.
Internal Medicine (Tokyo, Japan)|August 16, 2023
Pseudomesotheliomatous Carcinoma of the Lung with Morphological Characteristics of Signet Ring Cell Carcinoma: An Autopsy Case ReportTetsu Hirakawa, Takuya Tanimoto, Yui Hattori, et al.
International Journal of Clinical Oncology|July 6, 2026
Correction: Clinical implications of serum total VEGF-A and VEGF-A isoforms in patients with EGFR-mutated advanced non-small cell lung cancer treated with EGFR-TKIsTetsu Hirakawa, Kakuhiro Yamaguchi, Kiyofumi Shimoji, et al.
International Journal of Clinical Oncology|June 9, 2026
Clinical implications of serum total VEGF-A and VEGF-A isoforms in patients with EGFR-mutated advanced non-small cell lung cancer treated with EGFR-TKIsTetsu Hirakawa, Kakuhiro Yamaguchi, Kiyofumi Shimoji, et al.
Internal Medicine (Tokyo, Japan)|October 1, 2025
Diffuse Pulmonary Meningotheliomatosis Presenting with the Cheerios Sign Diagnosed by a Transbronchial Lung Cryobiopsy: A Case ReportTetsu Hirakawa, Kiyofumi Shimoji, Sachiko Shioya, et al.
Cancers|February 26, 2025
Predictive Value of Circulatory Total VEGF-A and VEGF-A Isoforms for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small-Cell Lung CancerTetsu Hirakawa, Kakuhiro Yamaguchi, Kunihiko Funaishi, et al.
Anticancer Research|July 7, 2021
Systemic Inflammatory Score Predicts Response and Prognosis in Patients With Lung Cancer Treated With ImmunotherapyJunichi Zaitsu, Yoshinori Yamashita, Akira Ishikawa, et al.
Pageof 2